The results of the aforementioned research prove that CLU glycosylation is crucial to the maintenance of its function and proteolytic cleavage is the key to chaperone activity exhibition by CLU under reducing conditions, e.g., in atherosclerosis [4]. This evidence concerns the gene CLU and atherosclerosis.